MYRIAD GENETICS, INC. Debt Securities, Available-for-sale, Amortized Cost
MYRIAD GENETICS, INC. (MYGN) had Debt Securities, Available-for-sale, Amortized Cost of $253.50 million as of 2020-06-30, per its 10-K filed 2020-08-13.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2020-08-13
- 2020-06-30: Debt Securities, Available-for-sale, Amortized Cost $253.50M.
- 2020-03-31: Debt Securities, Available-for-sale, Amortized Cost $223.80M.
- 2019-12-31: Debt Securities, Available-for-sale, Amortized Cost $188.60M.
- 2019-09-30: Debt Securities, Available-for-sale, Amortized Cost $193.50M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2020-06-30 | $253.50M 10-K · filed 2020-08-13 |
| 2020-03-31 | $223.80M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $188.60M 10-Q · filed 2020-02-07 |
| 2019-09-30 | $193.50M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $191.20M 10-K · filed 2020-08-13 |
| 2019-03-31 | $189.90M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $195.60M 10-Q · filed 2019-02-06 |
| 2018-06-30 | $211.90M 10-K · filed 2019-08-13 |
| 2015-03-31 | $175.55M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $229.47M 10-Q · filed 2015-02-04 |
| 2014-09-30 | $236.13M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $270.22M 10-K · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |